Dr. Gabriel Scally:

Perhaps Dr. Denton could help me out with the slides. She has been assisting to some extent with putting together the RCOG review. Deputy Kelly's questions are very apposite. He hinted there may be more than the 221 cases that have been identified. I think that is likely. We must go back to the way this review was run. It was entirely unsatisfactory in that they only looked at the cases of cervical cancer that they knew about, so they did not get a full data set, as happens with breast cancer, of all the cervical cancers from the cancer registry, which is the most complete register. They ran an alternative register of their own and the only cases they knew about were the ones they heard about or were notified within the screening service. That is not a good basis for a review, and it does not give one the kind of population data that would allow one to say how many cases of slides being wrongly or differently interpreted post a diagnosis of cervical cancer there were over the entire cervical cancer programmes in the country. There was a really big flaw at the beginning in terms of the design of the review.

In terms of us having the ability to go and look at those slides, first, what-----